REGENERON PHARMACEUTICALS, INC. Diversified Active

Location: Tarrytown, NY

CIK: 0000872589 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 2, 2025

Total Value: $1.234B (100.0% shares, 0.0% debt)

Holdings (6)

ALNY Alnylam Pharmaceuticals, Inc. 97.2%

Value $1.2B Shares 4,444,445 Est. Cost $262.99 Unrealized -2.3%

NTLA Intellia Therapeutics, Inc. 2.1%

Value $26.33M Shares 3,702,995 Est. Cost $15.61 Unrealized -35.3%

— 2seventy Bio, Inc. 0.5%

Value $6.199M Shares 1,254,827 Est. Cost $2.94 Unrealized —

— Adverum Biotechnologies, Inc. 0.1%

Value $791K Shares 180,909 Est. Cost $4.67 Unrealized —

— Adicet Bio, Inc. 0.1%

Value $731K Shares 968,183 Est. Cost $0.96 Unrealized —

— Bluebird Bio, Inc. 0.0%

Value $102K Shares 21,000 Est. Cost $8.34 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals, Inc.	4,444,445	$1.2B	97.2%	$262.99	-2.3%	Common Stock	02043Q107
NTLA	Intellia Therapeutics, Inc.	3,702,995	$26.33M	2.1%	$15.61	-35.3%	Common Stock	45826J105
—	2seventy Bio, Inc.	1,254,827	$6.199M	0.5%	$2.94	—	Common Stock	901384107
—	Adverum Biotechnologies, Inc.	180,909	$791K	0.1%	$4.67	—	Common Stock	00773U207
—	Adicet Bio, Inc.	968,183	$731K	0.1%	$0.96	—	Common Stock	007002108
—	Bluebird Bio, Inc.	21,000	$102K	0.0%	$8.34	—	Common Stock	09609G209